Lindsay, Colin R.
University of Manchester · The Christie NHS Foundation Trust
5 papers on CoChatORCID 0000-0001-8167-5461
Most cited papers
- Verified
Lung adenocarcinoma promotion by air pollutants
Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K., Kuan, F.-C., Marongiu, F., Evans, E. J., Moore, D. A., et al. (2023) · Nature
Air Quality and Health ImpactsCarcinogens and Genotoxicity Assessment
Cited by 808
- Verified
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
de Langen, A. J., Johnson, M. L., Mazieres, J., Dingemans, A.-M. C., Mountzios, G., Pless, M., Wolf, J., Schuler, M., Lena, H., Skoulidis, F., et al. (2023) · The Lancet
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 619
- Verified
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Abbosh, C., Frankell, A. M., Harrison, T., Kisistok, J., Garnett, A., Johnson, L., Veeriah, S., Moreau, M., Chesh, A., Chaunzwa, T. L., et al. (2023) · Nature
Cancer Genomics and DiagnosticsLung Cancer Diagnosis and Treatment
Cited by 382
- Verified
Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Dunnett-Kane, V., Burkitt-Wright, E., Blackhall, F. H., Malliri, A., Evans, D. G., & Lindsay, C. R. (2020) · Annals of Oncology
Neurofibromatosis and Schwannoma CasesProtein Tyrosine Phosphatases
Cited by 66
- Verified
More to the RAS Story: KRAS G12C Inhibition, Resistance Mechanisms, and Moving Beyond KRAS G12C
Lietman, C. D., Johnson, M. L., McCormick, F., & Lindsay, C. R. (2022) · American Society of Clinical Oncology Educational Book
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free